Specific Inhibition of P25/Cdk5 Activity by the Cdk5 Inhibitory Peptide Reduces Neurodegeneration in Vivo

Journal of Neuroscience - United States
doi 10.1523/jneurosci.3593-12.2013
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Society for Neuroscience

Related search

Inhibition of P25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia

Journal of Neuroscience
Neuroscience
2017English

Neuroprotective Mechanisms Mediated by CDK5 Inhibition

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2016English

Computational Study of the Inhibitory Mechanism of the Kinase CDK5 Hyperactivity by Peptide P5 and Derivation of a Pharmacophore

Journal of Computer-Aided Molecular Design
Theoretical ChemistryDrug DiscoveryComputer Science ApplicationsPhysical
2016English

Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice

Journal of Neuroscience
Neuroscience
2010English

Correction for Chow Et Al., CDK5 Activator Protein P25 Preferentially Binds and Activates GSK3β

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Cdk5 Protects Huntingtin

Journal of Cell Biology
MedicineCell Biology
2005English

Resveratrol Inhibits Cdk5 Activity Through Regulation of P35 Expression

Molecular Pain
Molecular MedicineAnesthesiologyPain MedicineCellularMolecular Neuroscience
2011English

CDK5 Inhibition In�vitro and in Vivo Induces Cell Death In�myeloma and Overcomes the Obstacle of Bortezomib Resistance

International Journal of Molecular Medicine
MedicineGenetics
2020English

S-Nitrosylation Activates Cdk5 and Contributes to Synaptic Spine Loss Induced by -Amyloid Peptide

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy